$EAR News

Last published 2y ago

2y agoEAREargo Debuts Two New Devices, Expanding Portfolio of Hearing Wellness OfferingsGlobeNewswireSAN JOSE, Calif., Jan. 31, 2024 (GLOBE NEWSWIRE) -- This quarter, Eargo, Inc. launches two new over-the-counter (OTC) hearing wellness devices, Eargo SE (launching today) and LINK by Eargo (launching in the first
2y agoEARWolf Popper LLP is Investigating Whether the Sale of Eargo, Inc. Is Fair to ShareholdersGlobeNewswireNEW YORK, Dec. 19, 2023 (GLOBE NEWSWIRE) -- Wolf Popper LLP is investigating claims on behalf of investors in Eargo, Inc. (NASDAQ:EAR) concerning the acquisition of Eargo by its controlling shareholder, Patient Square
3y agoCSTR DOC EAR SRCMoore Kuehn Encourages CSTR, DOC, EAR, and SRC Investors to Contact Law FirmGlobeNewswireNEW YORK, Nov. 01, 2023 (GLOBE NEWSWIRE) -- Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City, is investigating potential claims concerning whether the
3y agoEAREargo Celebrates 1-Year Anniversary of FDA's Over-the-Counter (OTC) Hearing Aid Regulations, Driving a New Era of Accessibility and InnovationGlobeNewswireSAN JOSE, Calif., Nov. 01, 2023 (GLOBE NEWSWIRE) -- Eargo, Inc. (NASDAQ:EAR) ("Eargo") celebrates the one-year anniversary of the creation of an over-the-counter (OTC) hearing aid category in the US. This important
3y agoEAREargo Expands Relationship with Best Buy, Growing In-Store Presence to Over 500 LocationsGlobeNewswireSAN JOSE, Calif., Oct. 26, 2023 (GLOBE NEWSWIRE) -- Eargo, Inc. (NASDAQ:EAR), a medical device company on a mission to improve the quality of life of people with hearing loss, today announced an expansion of its
3y agoEAREargo Reports Second Quarter 2023 Financial ResultsGlobeNewswireRecent Highlights: Net revenues of $8.1 million in the second quarter of 2023, up 12% year-over-yearGross systems shipped of 5,098, up 14% year-over-yearGAAP total operating loss $25.8 million in the second quarter of
3y agoEAREargo, Inc. (EAR) Q1 2023 Earnings Call TranscriptEarnings Call Transcripts
3y agoEAREargo Reports First Quarter 2023 Financial ResultsGlobeNewswireRecent Highlights: Net revenues of $11.8 million in the first quarter of 2023, up 29% year-over-yearGross systems shipped of 8,705, up 51% year-over-yearGAAP total operating loss $22.8 million in the first quarter of
3y agoEAREargo to Report First Quarter 2023 Financial Results on May 11, 2023GlobeNewswireSAN JOSE, Calif., May 04, 2023 (GLOBE NEWSWIRE) -- Eargo, Inc. (NASDAQ:EAR), a medical device company on a mission to improve hearing health, today announced it will release financial results for the first quarter 2023
3y agoEAREargo Reports Fourth Quarter 2022 Financial ResultsGlobeNewswireRecent Highlights: Net revenues of $12.9 million in the fourth quarter of 2022, compared to $10.1 million in the fourth quarter of 2021 and $7.9 million in the third quarter of 2022Gross systems shipped of 8,863,
3y agoEAREargo to Report Fourth Quarter 2022 Financial Results on March 23, 2023GlobeNewswireSAN JOSE, Calif., March 17, 2023 (GLOBE NEWSWIRE) -- Eargo, Inc. (NASDAQ:EAR), a medical device company on a mission to improve hearing health, today announced it will release financial results for the fourth quarter
3y agoEARNasdaq Confirms Eargo's Minimum Bid Price Deficiency is CuredGlobeNewswireSAN JOSE, Calif., Feb. 06, 2023 (GLOBE NEWSWIRE) -- Eargo, Inc. (NASDAQ:EAR) (the "Company" or "Eargo"), a medical device company on a mission to improve the quality of life of people with hearing loss, announced today
3y agoEAREargo Effects 1-for-20 Reverse Stock SplitGlobeNewswireSAN JOSE, Calif., Jan. 17, 2023 (GLOBE NEWSWIRE) -- Eargo, Inc. ("Eargo" or the "Company") (NASDAQ:EAR), a medical device company on a mission to improve the quality of life for people with hearing loss, today
3y agoEAREargo to Complete a 1-for-20 Reverse Stock SplitGlobeNewswireSAN JOSE, Calif., Jan. 11, 2023 (GLOBE NEWSWIRE) -- Eargo, Inc. ("Eargo" or the "Company") (NASDAQ:EAR), a medical device company on a mission to improve the quality of life for people with hearing loss, today
3y agoEARHearing Wellness Pioneer Eargo Launches Eargo 7, Its Most Revolutionary Device Yet, at CESGlobeNewswireEARGO 7 OFFERS CLARITY MODE, CREATING ITS MOST NATURAL HEARING EXPERIENCE FOR THOSE WITH MILD TO MODERATE HEARING LOSS NEW OTC DEVICE TO BE AVAILABLE IN-STORE THROUGH PARTNERSHIP WITH VICTRA, ONE OF AMERICA'S LARGEST
3y agoEARNationsBenefits and Eargo Announce Partnership to Offer Over-the-Counter Hearing AidsBusiness WireEargo Hearing Aids will be available Over-the-Counter beginning January 1, 2023 NationsBenefits®, a leading provider of supplemental benefits, flex cards, and member engagement solutions for health plans, and
3y agoEAREargo and NationsBenefits Announce Strategic PartnershipGlobeNewswireSAN JOSE, Calif., Dec. 12, 2022 (GLOBE NEWSWIRE) -- Eargo, Inc. (NASDAQ:EAR), a medical device company on a mission to improve the quality of life for people with hearing loss, and NationsBenefits, (a leading provider
3y agoEAR ITGR VAPOEargo Announces Strategic Additions to Board of Directors Following Patient Square Capital Becoming New Majority ShareholderGlobeNewswireSAN JOSE, Calif., Dec. 07, 2022 (GLOBE NEWSWIRE) -- Eargo, Inc. ("Eargo" or the "Company") (NASDAQ:EAR), a medical device company on a mission to improve the quality of life for people with hearing loss, today
3y agoEAREargo, Inc. Welcomes Patient Square Capital As New Majority Owner Following Rights OfferingGlobeNewswireSAN JOSE, Calif., Nov. 29, 2022 (GLOBE NEWSWIRE) -- Eargo, Inc. (NASDAQ:EAR) ("Eargo" or "the Company"), a medical device company on a mission to improve the quality of life of people with hearing loss, is pleased to
3y agoEAREargo Announces Closing of Rights Offering and Conversion of Patient Square Notes Into Shares of Eargo Common StockGlobeNewswireSAN JOSE, Calif., Nov. 29, 2022 (GLOBE NEWSWIRE) -- Eargo, Inc. ("Eargo" or the "Company") (NASDAQ:EAR), a medical device company on a mission to improve the quality of life for people with hearing loss, announced
3y agoEARImportant Reminder for Eargo Stockholders of Record as of October 24, 2022GlobeNewswireDEADLINE TO PARTICIPATE IN EARGO RIGHTS OFFERING IS TOMORROW, NOVEMBER 17, 2022: FOR U.S. HOLDERS WHO HOLD SHARES THROUGH A BROKERAGE ACCOUNT: 2:15 P.M., NEW YORK CITY TIME, ON NOVEMBER 17, 2022, SUBJECT TO ANY OTHER
3y agoEARImportant Reminder for Eargo Stockholders of Record as of October 24, 2022GlobeNewswireDEADLINE TO PARTICIPATE IN EARGO RIGHTS OFFERING FOR U.S. HOLDERS WHO HOLD SHARES THROUGH A BROKERAGE ACCOUNT:2:15 P.M., NEW YORK CITY TIME, ON NOVEMBER 17, 2022,SUBJECT TO ANY OTHER DEADLINES SET BY YOUR BROKER
4y agoEARImportant Reminder for Eargo Stockholders of Record as of October 24, 2022GlobeNewswireDEADLINE TO PARTICIPATE IN EARGO RIGHTS OFFERING FOR U.S. REGISTERED HOLDERS: 5:00 P.M., NEW YORK CITY TIME, ON NOVEMBER 17, 2022 DEADLINE TO PARTICIPATE IN EARGO RIGHTS OFFERING FOR U.S. HOLDERS WHO HOLD SHARES
4y agoEAREargo Announces Issuance of Quarterly Report for Third Fiscal QuarterGlobeNewswireSAN JOSE, Calif., Nov. 07, 2022 (GLOBE NEWSWIRE) -- Eargo, Inc. ("Eargo" or the "Company") (NASDAQ:EAR), a medical device company on a mission to improve the quality of life for people with hearing loss, today
4y agoEAREargo Now Available for Purchase in ~1,500 Victra Wireless Stores NationwideGlobeNewswireSAN JOSE, Calif., Nov. 03, 2022 (GLOBE NEWSWIRE) -- Eargo, Inc. (NASDAQ:EAR), a medical device company on a mission to improve the quality of life for people with hearing loss, today announced the availability of Eargo
4y agoEAREargo Reports Third Quarter 2022 Financial ResultsGlobeNewswireThird Quarter 2022 Highlights: Net revenues of $7.9 million, compared to ($22.9) million in the prior year periodGross systems shipped of 5,156, compared to 13,117 in the prior year periodReturn accrual rate of 32.3%,
4y agoEAREargo Announces Commencement of Rights OfferingGlobeNewswireSAN JOSE, Calif., Oct. 31, 2022 (GLOBE NEWSWIRE) -- Eargo, Inc. ("Eargo" or the "Company") (NASDAQ:EAR), a medical device company on a mission to improve the quality of life for people with hearing loss, today
4y agoEAREargo to Report Third Quarter 2022 Financial Results on November 3, 2022GlobeNewswireSAN JOSE, Calif., Oct. 27, 2022 (GLOBE NEWSWIRE) -- Eargo, Inc. (NASDAQ:EAR), a medical device company on a mission to improve hearing health, today announced it will release financial results for the third quarter
4y agoEAREargo Announces Record Date for Proposed Rights OfferingGlobeNewswireRecord Date established as October 24, 2022To be a stockholder of record, investors are advised to own EAR stock by 4:00 p.m. Eastern Time on Thursday, October 20, 2022 to account for T (trade) +2 settlement timing SAN
4y agoEAREargo to Hold Investor Update Conference Call on October 4, 2022GlobeNewswireConference Call to be held on Tuesday, October 4, 2022 at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time) VOTE now to ensure the Company can conduct its proposed rights offering and repay or convert the convertible notes held by Patient Square Capital
4y agoEAREargo Announces Proxy Solicitation for 2022 Annual Meeting; Launch of Proxy Solicitation Web SiteGlobeNewswireSAN JOSE, Calif., Sept. 20, 2022 (GLOBE NEWSWIRE) -- Eargo, Inc. (NASDAQ:EAR) ("Eargo", the "Company," "we," or "us"), a medical device company on a mission to improve hearing health, today announced that it had begun its proxy solicitation for the 202
4y agoEAREargo Supports Over-the-Counter Hearing Aid Final RulingGlobeNewswireSAN JOSE, Calif., Aug. 17, 2022 (GLOBE NEWSWIRE) -- Eargo, Inc. (NASDAQ:EAR) ("Eargo" or the "Company"), a medical device company on a mission to improve hearing health, announced its support of the new regulatory category of over-the-counter ("OTC")
4y agoEAREargo Reports Second Quarter 2022 Financial ResultsGlobeNewswireFinancing Update: Strengthened financial position with up to $125 million strategic investment from Patient Square Capital (the "Note Transaction"); closed first tranche investment of $100 million senior secured convertible notes on June 28, 2022 Co
4y agoEAREargo, Inc. (EAR) Q2 2022 Earnings Call TranscriptEarnings Call TranscriptsEAR earnings call for the period ending June 30, 2022.
4y agoEAREargo to Report Second Quarter 2022 Financial Results on August 8, 2022GlobeNewswireSAN JOSE, Calif., July 28, 2022 (GLOBE NEWSWIRE) -- Eargo, Inc. (NASDAQ:EAR), a medical device company on a mission to improve hearing health, today announced it will release financial results for the second quarter 2022 after market close on August 8,
4y agoEAREargo Closes First Tranche Investment of $100 Million from Patient Square CapitalGlobeNewswireSAN JOSE, Calif., July 05, 2022 (GLOBE NEWSWIRE) -- Eargo, Inc. (NASDAQ:EAR) (the "Company"), a medical device company on a mission to improve the quality of life of people with hearing loss, today announced it has completed the issuance of $100 millio
4y agoEAREargo Strengthens Financial Position with up to $125 Million Strategic Investment from Patient Square CapitalGlobeNewswireSAN JOSE, Calif., June 27, 2022 (GLOBE NEWSWIRE) -- Eargo, Inc. (NASDAQ:EAR) (the "Company"), a medical device company on a mission to improve the quality of life of people with hearing loss, today announced it has signed a definitive agreement with Pa
4y agoEAREargo to Present at the William Blair 42nd Annual Growth Stock ConferenceGlobeNewswireSAN JOSE, Calif., June 02, 2022 (GLOBE NEWSWIRE) -- Eargo, Inc. (NASDAQ:EAR), a medical device company on a mission to improve the quality of life for people with hearing loss, today announced it will present at the William Blair 42nd Annual Growth Sto
4y agoEARNasdaq Confirms Continued Listing of Eargo StockGlobeNewswireSAN JOSE, Calif., May 31, 2022 (GLOBE NEWSWIRE) -- Eargo, Inc. (NASDAQ:EAR) (the "Company" or "Eargo"), a medical device company on a mission to improve the quality of life of people with hearing loss, announced today that it received a letter from The
4y agoEAREargo Announces Receipt of Nasdaq Non-Compliance LetterGlobeNewswireSAN JOSE, Calif., May 13, 2022 (GLOBE NEWSWIRE) -- Eargo, Inc. (NASDAQ:EAR) (the "Company" or "Eargo"), a medical device company on a mission to improve the quality of life of people with hearing loss, today announced the Company received a letter (the
4y agoEAREargo Provides Business UpdateGlobeNewswireReached settlement agreement to resolve DOJ investigation Company to Hold Conference Call and Web Cast on May 2, 2022 at 8 a.m. Eastern Time SAN JOSE, Calif., April 29, 2022 (GLOBE NEWSWIRE) -- Eargo, Inc. (NASDAQ:EAR) (the "Company"), a medical
4y agoEAREargo Finalizes Agreement with the United States to Resolve Investigation With No Admission of LiabilityGlobeNewswireSAN JOSE, Calif., April 29, 2022 (GLOBE NEWSWIRE) -- Eargo, Inc. (NASDAQ:EAR) ("Eargo" or the "Company") has entered into a civil settlement agreement with the United States to resolve the previously disclosed investigation by the U.S. Department of Ju
4y agoEAREargo Receives Notification from Nasdaq Related to Delayed Annual Report on Form 10-KGlobeNewswireSAN JOSE, Calif., March 10, 2022 (GLOBE NEWSWIRE) -- Eargo, Inc. (NASDAQ:EAR) (the "Company" or "Eargo"), a medical device company on a mission to improve the quality of life of people with hearing loss, today announced the Company received a letter fr
4y agoEAREargo Applauds Proposed Rule for OTC Hearing Aids and Submits Public Comments to FDAGlobeNewswireSAN JOSE, Calif., Jan. 20, 2022 (GLOBE NEWSWIRE) -- Eargo, Inc. (NASDAQ:EAR), a medical device company on a mission to improve the quality of life of people with hearing loss, today announced the submission of public comments to the Food and Drug Admin
4y agoBEKE EAR F SPCE+1Thinking about buying stock in Ford, Siyata Mobile, Eargo, Virgin Galactic, or KE Holdings?PR NewswireNEW YORK, Jan. 7, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for F, SYTA, EAR, SPCE, and BEKE. To s
4y agoEAR KAVL KGC PLTR+1Thinking about buying stock in Eargo Inc, Kaival Brands Innovations, Palantir Technologies, Vodafone, or Kinross Gold?PR NewswireNEW YORK, Jan. 6, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for EAR, KAVL, PLTR, VOD, and KGC. To
4y agoEAREargo Launches Eargo 6 with Sound Adjust for Effortless HearingGlobeNewswireLAS VEGAS, Jan. 04, 2022 (GLOBE NEWSWIRE) -- Eargo, Inc. (NASDAQ:EAR), a medical device company on a mission to improve the quality of life of people with hearing loss, today launched Eargo 6, its sixth-generation FDA Class II exempt hearing aid and mo
4y agoEAREargo Receives Notification from Nasdaq Related to Delayed Quarterly Report on Form 10-QGlobeNewswireSAN JOSE, Calif., Nov. 22, 2021 (GLOBE NEWSWIRE) -- Eargo, Inc. (NASDAQ:EAR) (the "Company" or "Eargo"), a medical device company on a mission to improve the quality of life of people with hearing loss, today announced the Company received a letter fro
5y agoEARLost Money in Eargo, Inc.?Business WireGibbs Law Group Investigates Potential Securities Law Violations Shares of recent IPO Eargo, Inc. dropped another 5% on intraday trading Tuesday, September 28, 2021 after admitting in an SEC filing on Wednesday, September 24 that the company was faci
5y agoEAR FCEL NAK NAKD+1Thinking about buying stock in Naked Brand, Northern Dynasty Minerals, FuelCell Energy, SmileDirectClub, or Eargo?PR NewswireNEW YORK, Sept. 24, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for NAKD, NAK, FCEL, SDC, and EAR. T